Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Human EFNA3 Protein, N-His-SUMO

Recombinant Human EFNA3 Protein, N-His-SUMO from ProteoGenix; catalogue ARO-P11322; research use only.

SKU:
ABM141761-1
Manufacturer SKU
ARO-P11322
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Introduction

Recombinant Human EFNA3 Protein, also known as ephrin-A3, is a member of the ephrin family of proteins. It is a glycosylphosphatidylinositol (GPI)-anchored protein that plays a crucial role in cell signaling and tissue development. In this article, we will discuss the structure, activity, and application of Recombinant Human EFNA3 Protein.

Structure of Recombinant Human EFNA3 Protein

Recombinant Human EFNA3 Protein is a 33 kDa protein consisting of 231 amino acids. It contains a conserved N-terminal ephrin domain, a transmembrane region, and a C-terminal GPI anchor. The ephrin domain is responsible for binding to its receptor, EphA receptors, and initiating downstream signaling pathways.

Activity of Recombinant Human EFNA3 Protein

Recombinant Human EFNA3 Protein is a potent ligand for EphA receptors, specifically EphA4 and EphA5. Binding of EFNA3 to these receptors leads to the activation of multiple signaling pathways, including the mitogen-activated protein kinase (MAPK) pathway and the phosphoinositide 3-kinase (PI3K) pathway. These pathways are involved in cell proliferation, survival, and differentiation.

In addition to its role in cell signaling, EFNA3 also plays a crucial role in tissue development. It is involved in axon guidance, neuronal migration, and synapse formation. EFNA3 is also known to regulate cell adhesion and motility, which are important processes in tissue development and wound healing.

Application of Recombinant Human EFNA3 Protein

Due to its role in cell signaling and tissue development, Recombinant Human EFNA3 Protein has various applications in the field of research and medicine. Some of these applications include:

1. Recombinant Protein Production

Recombinant Human EFNA3 Protein is widely used as a recombinant protein in various research studies. It can be produced in large quantities using recombinant DNA technology, making it easily accessible for research purposes.

2. Antigen for Antibody Production

EFNA3 has been identified as a potential antigen for antibody production. Antibodies against EFNA3 can be used to study its expression and function in different tissues and cell types. These antibodies can also be used in diagnostic tests for diseases associated with EFNA3 dysregulation.

3. Potential Therapeutic Target

The dysregulation of EFNA3 has been linked to various diseases, including cancer, Alzheimer’s disease, and multiple sclerosis. Therefore, EFNA3 is being explored as a potential therapeutic target for these diseases. Recombinant Human EFNA3 Protein can be used in preclinical studies to evaluate its efficacy as a therapeutic target.

4. Tissue Engineering

EFNA3’s role in tissue development and wound healing makes it a potential candidate for tissue engineering applications. Recombinant Human EFNA3 Protein can be used to promote cell adhesion and migration, leading to the formation of functional tissues.

5. Drug Screening

The dysregulation of EFNA3 has been implicated in drug resistance in cancer cells. Recombinant Human EFNA3 Protein can be used in drug screening assays to identify potential compounds that can target EFNA3 and overcome drug resistance.

Conclusion

In summary, Recombinant Human EFNA3 Protein is a crucial protein involved in cell signaling and tissue development. Its structure, activity, and various applications make it a valuable tool in research and medicine. Further studies on EFNA3 and its interactions with other proteins and receptors may lead to the development of new therapies for diseases associated with its dysregulation.

ProteoGenix catalogue number ARO-P11322. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 28.01 kDa; Fragment: Gly30-Val165; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
EPLG3, EPH-related receptor tyrosine kinase ligand 3, EFL2, LERK-3, EFNA3, Ephrin-A3, LERK3, EFL-2, EHK1-L, EHK1 ligand
Host species
E. coli
Source organism
Human
Molecular weight
28.01 kDa
Sequence fragment
Gly30-Val165
Sequence
GNRHAVYWNSSNQHLRREGYTVQVNVNDYLDIYCPHYNSSGVGPGAGPGPGGGAEQYVLYMVSRNGYRTCNASQGFKRWECNRPHAPHSPIKFSEKFQRYSAFSLGYEFHAGHEYYYISTPTHNLHWKCLRMKVFV
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P11322
UniProt accession
P52797
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£215.00£172.00